Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EDAP Edap Tms	$2.15 -3.2%	$1.96	$1.26 ▼ $7.11	$79.77M	0.13	96,983 shs	88,833 shs
IRIX IRIDEX	$1.15	$1.05	$0.78 ▼ $3.25	$19.31M	0.69	45,999 shs	99,521 shs
RMTI Rockwell Medical	$1.04 -7.1%	$1.23	$0.86 ▼ $5.15	$35.54M	1.64	422,235 shs	773,737 shs
SIBN SI-BONE	$18.78 +1.6%	$14.57	$11.70 ▼ $19.35	$798.70M	0.82	370,053 shs	652,844 shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EDAP Edap Tms	0.00%	0.00%	+56.34%	-11.20%	-68.73%
IRIX IRIDEX	0.00%	-2.94%	+22.55%	-28.26%	-59.33%
RMTI Rockwell Medical	0.00%	-9.35%	+5.19%	-40.37%	-32.01%
SIBN SI-BONE	0.00%	+32.31%	+38.44%	+8.44%	+20.74%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EDAP Edap Tms	2.8162 of 5 stars	3.3	5.0	0.0	2.0	1.7	0.6
IRIX IRIDEX	2.2295 of 5 stars	3.0	4.0	0.0	3.3	1.7	0.0
RMTI Rockwell Medical	4.1711 of 5 stars	3.7	5.0	4.1	1.6	1.7	0.0
SIBN SI-BONE	3.5684 of 5 stars	2.5	3.0	3.3	2.6	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EDAP Edap Tms	2.67	Moderate Buy	$8.50	295.35% Upside
IRIX IRIDEX	2.00	Hold	$2.00	73.91% Upside
RMTI Rockwell Medical	3.33	Buy	$4.00	284.62% Upside
SIBN SI-BONE	3.00	Buy	$22.50	19.81% Upside

Current Analyst Ratings Breakdown

Latest EDAP, RMTI, IRIX, and SIBN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/6/2025	SIBN SI-BONE	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$20.00 ➝ $22.00
5/6/2025	SIBN SI-BONE	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$25.00 ➝ $25.00
5/6/2025	SIBN SI-BONE	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$24.00 ➝ $24.00
4/4/2025	EDAP Edap Tms	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$8.00 ➝ $2.00
3/28/2025	EDAP Edap Tms	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$5.00 ➝ $4.50
3/28/2025	EDAP Edap Tms	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$19.00 ➝ $19.00
3/24/2025	RMTI Rockwell Medical	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$7.00 ➝ $3.00
2/25/2025	SIBN SI-BONE	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$18.00 ➝ $22.00
2/25/2025	SIBN SI-BONE	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$25.00 ➝ $25.00
2/25/2025	SIBN SI-BONE	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$20.00 ➝ $24.00

(Data available from 5/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EDAP Edap Tms	$64.12M	1.24	N/A	N/A	$1.66 per share	1.30
IRIX IRIDEX	$48.67M	0.40	N/A	N/A	$0.59 per share	1.95
RMTI Rockwell Medical	$101.49M	0.35	$0.01 per share	92.73	$0.75 per share	1.39
SIBN SI-BONE	$176.60M	4.52	N/A	N/A	$4.18 per share	4.49

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EDAP Edap Tms	-$22.92M	-$0.55	N/A	N/A	N/A	-34.92%	-44.21%	-25.88%	5/15/2025 (Estimated)
IRIX IRIDEX	-$9.57M	-$0.54	N/A	∞	N/A	-22.79%	-192.95%	-33.97%	5/13/2025 (Estimated)
RMTI Rockwell Medical	-$8.44M	-$0.02	N/A	N/A	N/A	-1.25%	8.55%	3.80%	5/12/2025 (Estimated)
SIBN SI-BONE	-$43.34M	-$0.64	N/A	N/A	N/A	-23.82%	-22.51%	-16.53%	N/A

Latest EDAP, RMTI, IRIX, and SIBN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/15/2025	Q1 2025	EDAP Edap Tms	-$0.16	N/A	N/A	N/A	$16.56 million	N/A
5/12/2025	Q1 2025	RMTI Rockwell Medical	-$0.03	-$0.04	-$0.01	-$0.04	$17.46 million	$18.91 million
5/5/2025	Q1 2025	SIBN SI-BONE	-$0.24	-$0.15	+$0.09	-$0.15	$45.13 million	$47.29 million
3/27/2025	Q4 2024	EDAP Edap Tms	-$0.11	-$0.05	+$0.06	-$0.05	$20.83 million	$22.69 million
3/27/2025	Q4 2024	IRIX IRIDEX	-$0.05	-$0.05	N/A	-$0.05	$12.80 million	$12.70 million
3/20/2025	Q4 2024	RMTI Rockwell Medical	$0.02	-$0.02	-$0.04	-$0.02	$23.65 million	$24.67 million
2/24/2025	Q4 2024	SIBN SI-BONE	-$0.16	-$0.11	+$0.05	-$0.11	$48.87 million	$49.00 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EDAP Edap Tms	N/A	N/A	N/A	N/A	N/A
IRIX IRIDEX	N/A	N/A	N/A	N/A	N/A
RMTI Rockwell Medical	N/A	N/A	N/A	N/A	N/A
SIBN SI-BONE	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EDAP Edap Tms	0.08	2.18	1.46
IRIX IRIDEX	0.55	1.54	0.85
RMTI Rockwell Medical	0.33	2.41	2.00
SIBN SI-BONE	0.22	8.25	7.22

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EDAP Edap Tms	62.74%
IRIX IRIDEX	20.10%
RMTI Rockwell Medical	23.31%
SIBN SI-BONE	98.11%

Insider Ownership

Company	Insider Ownership
EDAP Edap Tms	0.23%
IRIX IRIDEX	7.30%
RMTI Rockwell Medical	3.60%
SIBN SI-BONE	4.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EDAP Edap Tms	230	37.10 million	37.02 million	Optionable
IRIX IRIDEX	120	16.79 million	15.42 million	Optionable
RMTI Rockwell Medical	300	34.18 million	31.71 million	Optionable
SIBN SI-BONE	350	42.53 million	40.30 million	Optionable

EDAP, RMTI, IRIX, and SIBN Headlines

Recent News About These Companies

SI-BONE, Inc. (NASDAQ:SIBN) Shares Sold by Granahan Investment Management LLC

May 12 at 6:35 AM | marketbeat.com

SI-BONE, Inc. (NASDAQ:SIBN) CFO Anshul Maheshwari Sells 4,937 Shares

May 10 at 6:36 AM | insidertrades.com

Earnings Update: SI-BONE, Inc. (NASDAQ:SIBN) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

May 9 at 12:28 PM | finance.yahoo.com

Wall Street Analysts Think Si-Bone (SIBN) Could Surge 41.21%: Read This Before Placing a Bet

May 8, 2025 | zacks.com

SI-BONE (NASDAQ:SIBN) Shares Gap Up After Strong Earnings

May 8, 2025 | marketbeat.com

SI-BONE's (SIBN) "Overweight" Rating Reiterated at Cantor Fitzgerald

May 8, 2025 | marketbeat.com

Needham & Company LLC Reaffirms "Buy" Rating for SI-BONE (NASDAQ:SIBN)

May 8, 2025 | marketbeat.com

Tudor Investment Corp ET AL Has $1.25 Million Holdings in SI-BONE, Inc. (NASDAQ:SIBN)

May 8, 2025 | marketbeat.com

SI-BONE (NASDAQ:SIBN) Shares Gap Up Following Earnings Beat

May 8, 2025 | americanbankingnews.com

SI-BONE Inc. Q1 Loss Decreases, Beats Estimates

May 7, 2025 | nasdaq.com

SI-BONE (NASDAQ:SIBN) Announces Earnings Results

May 7, 2025 | marketbeat.com

SI-BONE, Inc. (NASDAQ:SIBN) Shares Sold by Brown Advisory Inc.

May 7, 2025 | marketbeat.com

SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025

May 6, 2025 | globenewswire.com

Bellevue Group AG Has $12.35 Million Stock Position in SI-BONE, Inc. (NASDAQ:SIBN)

May 6, 2025 | marketbeat.com

Raymond James Financial Inc. Invests $1.23 Million in SI-BONE, Inc. (NASDAQ:SIBN)

May 6, 2025 | marketbeat.com

SI-BONE, Inc. Reports Strong Q1 2025 Growth

May 6, 2025 | tipranks.com

SI-BONE, Inc. (SIBN) Q1 2025 Earnings Call Transcript

May 5, 2025 | seekingalpha.com

Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates

May 5, 2025 | zacks.com

SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance

May 5, 2025 | globenewswire.com

CANADA LIFE ASSURANCE Co Has $54,000 Position in SI-BONE, Inc. (NASDAQ:SIBN)

May 3, 2025 | marketbeat.com

SI-BONE (SIBN) to Release Quarterly Earnings on Monday

May 3, 2025 | americanbankingnews.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

EDAP, RMTI, IRIX, and SIBN Company Descriptions

Edap Tms NASDAQ:EDAP

$2.13 -0.09 (-3.87%)

As of 04:00 PM Eastern

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

IRIDEX NASDAQ:IRIX

$1.15 0.00 (0.00%)

Closing price 03:59 PM Eastern

Extended Trading

$1.16 +0.01 (+0.87%)

As of 07:40 PM Eastern

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Rockwell Medical NASDAQ:RMTI

$1.04 -0.08 (-7.14%)

Closing price 04:00 PM Eastern

Extended Trading

$1.07 +0.03 (+3.27%)

As of 07:32 PM Eastern

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

SI-BONE NASDAQ:SIBN

$18.78 +0.29 (+1.57%)

Closing price 04:00 PM Eastern

Extended Trading

$18.79 +0.01 (+0.05%)

As of 04:53 PM Eastern

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time